The U.S. FDA relied on a critically flawed risk-benefit assessment to authorize emergency use of Pfizer’s COVID-19 vaccine for children 5-11 years of age.
Research shows increases in COVID-19 cases are completely unrelated to levels of vaccination in 68 countries worldwide and 2,947 counties in the U.S.